Effect of direct renin-inhibition aliskiren on renal haemodynamic and metabolic parameters in patients with prediabetes.
Phase of Trial: Phase III
Latest Information Update: 26 May 2014
At a glance
- Drugs Aliskiren (Primary)
- Indications Glucose metabolism disorders; Hypertension
- Focus Pharmacodynamics
- Acronyms AMARYLIS
- 29 Mar 2014 Trial status changed to completed as reported by European Clinical Trials Database.
- 26 Apr 2012 New trial record